Should you buy DENTSPLY SIRONA (XRAY)?
Updated
Dentsply Sirona trades at a deeply discounted forward P/E of 6.6x with 32% analyst upside from current levels, but the business is in a confirmed downtrend, has missed earnings in 2 of the last 4 quarters, and carries an elevated put-to-call ratio of 8.50 that signals heightened institutional hedging activity.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
| Pillar | Expectation | Trend |
|---|---|---|
With a forward P/E of 6.6x, a PEG ratio of 0.72, and peer-ranking in the top decile for value, Dentsply is priced as a deep-value recovery candidate, but that valuation reflects genuine fundamental weakness rather than temporary mispricing given the quality score of 3.5. Valuation breakdown | Forward earnings estimates stabilize and begin rising, pushing the forward P/E above 8x within 12 months as cost restructuring gains traction. | →Stable |
| CounterDental equipment companies facing competitive and procedural-volume headwinds have historically stayed cheap for multiple years during restructuring cycles before realizing valuation expansion. | ||
A Piotroski F-Score of 8 out of 9, positive free cash flow with a 4% FCF margin and 6.4% FCF yield, and volume accumulation on the chart suggest the company's core cash generation is more intact than the quality score and sentiment imply. Quality breakdown | FCF margin improves above 6% within 12 months as operating expenses are restructured and dental demand volumes recover. | →Stable |
| CounterFCF margins of 4% in a medical instruments company with no competitive moat and declining revenue trends are not high enough to drive multiple expansion on their own. | ||
Dentsply has missed earnings in 2 of the last 4 quarters with an average surprise of negative 5.5%, and the 200-day moving average is declining at negative 4.7% per month, combining fundamental and technical evidence of a company struggling to stabilize its earnings trajectory. Earnings | EPS beats emerge in at least 2 of the next 4 quarters and the average EPS surprise turns positive, above 0%, signaling the earnings trough has been reached. | →Stable |
| CounterDental equipment demand is tied to dental office capital spending cycles, which tend to be multi-year in duration, making rapid earnings recovery unlikely without a meaningful catalyst. | ||
With a forward P/E of 6.6x, a PEG ratio of 0.72, and peer-ranking in the top decile for value, Dentsply is priced as a deep-value recovery candidate, but that valuation reflects genuine fundamental weakness rather than temporary mispricing given the quality score of 3.5.
→Stable- Expectation
- Forward earnings estimates stabilize and begin rising, pushing the forward P/E above 8x within 12 months as cost restructuring gains traction.
CounterDental equipment companies facing competitive and procedural-volume headwinds have historically stayed cheap for multiple years during restructuring cycles before realizing valuation expansion.
A Piotroski F-Score of 8 out of 9, positive free cash flow with a 4% FCF margin and 6.4% FCF yield, and volume accumulation on the chart suggest the company's core cash generation is more intact than the quality score and sentiment imply.
→Stable- Expectation
- FCF margin improves above 6% within 12 months as operating expenses are restructured and dental demand volumes recover.
CounterFCF margins of 4% in a medical instruments company with no competitive moat and declining revenue trends are not high enough to drive multiple expansion on their own.
Dentsply has missed earnings in 2 of the last 4 quarters with an average surprise of negative 5.5%, and the 200-day moving average is declining at negative 4.7% per month, combining fundamental and technical evidence of a company struggling to stabilize its earnings trajectory.
→Stable- Expectation
- EPS beats emerge in at least 2 of the next 4 quarters and the average EPS surprise turns positive, above 0%, signaling the earnings trough has been reached.
CounterDental equipment demand is tied to dental office capital spending cycles, which tend to be multi-year in duration, making rapid earnings recovery unlikely without a meaningful catalyst.
▸ Show 1 more pillar▾ Show fewer
A put-to-call ratio of 8.50 is among the highest in the screened universe and indicates that options market participants are paying a substantial premium to hedge downside risk, which is consistent with the earnings miss pattern and quality concerns.
→Stable- Expectation
- Put-to-call ratio falls below 3.0 within 12 months as earnings stabilize and hedging demand eases, reducing the implied uncertainty premium in options pricing.
CounterElevated put-to-call ratios can be contrarian bullish signals when they reach extremes, as they may reflect maximum pessimism before a sentiment reversal.
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1With a forward P/E of 6.6x, a PEG ratio of 0.72, and peer-ranking in the top decile for value, Dentsply is priced as a deep-value recovery candidate, but that valuation reflects genuine fundamental weakness rather than temporary mispricing given the quality score of 3.5.
Trip ifForward earnings estimates decline by more than 20% from current levels, pushing the forward P/E above 8x on lower estimates rather than price appreciation.
- P2Dentsply has missed earnings in 2 of the last 4 quarters with an average surprise of negative 5.5%, and the 200-day moving average is declining at negative 4.7% per month, combining fundamental and technical evidence of a company struggling to stabilize its earnings trajectory.
Trip ifEPS surprise falls below negative 5% in at least 3 of the next 4 quarters, indicating deterioration is accelerating.
- P3A put-to-call ratio of 8.50 is among the highest in the screened universe and indicates that options market participants are paying a substantial premium to hedge downside risk, which is consistent with the earnings miss pattern and quality concerns.
Trip ifPut-to-call ratio rises above 12.0, increasing more than 41% above the already elevated current level of 8.50.
- P4A Piotroski F-Score of 8 out of 9, positive free cash flow with a 4% FCF margin and 6.4% FCF yield, and volume accumulation on the chart suggest the company's core cash generation is more intact than the quality score and sentiment imply.
Trip ifPrice falls below $9.43 stop-loss, declining more than 7% from the current $10.14.
How the engine reached this verdict
TrendMatrix's engine output for DENTSPLY SIRONA Inc. (XRAY) is SELL_IF_HOLDING with medium conviction, score 4.8/10 at $10.75. An L1 hard-floor gate blocked the positive-verdict path — Quality below minimum threshold. Co-failing gates ( ASYMMETRY:1.0<1.5@spot) reinforce the read; dimensional pillars cannot lift the engine output above the verdict floor while the L1 gate is active.
The engine's exit framework anchors to a tactical sell band near $10.75, with structural invalidation at $10.02. The asymmetric R:R against a reversal hypothesis is 1.71 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
On the bear side: Quality below floor (3.5 < 4.0). Active engine warnings: Quality below floor (3.5 < 4.0), V9 Gate Failed: ASYMMETRY:1.0<1.5@spot.
The dominant failed gate is reward-to-risk at 1.0 vs threshold 1.5. SELL flips back toward HOLD if reward-to-risk recovers above its threshold AND a co-failing gate also clears. The strongest-cleared gate today is MOMENTUM:5.5>=5.5.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates XRAY — 10-dimension breakdown →
Bear case
- ▸Quality below floor (3.5 < 4.0)